Skin Toxicity by Oncological Therapies
Condition(s):Skin ToxicityLast Updated:March 2, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Skin ToxicityLast Updated:March 2, 2023Recruiting
Condition(s):Solid Tumor, Adult; Breast Cancer; Lung CancerLast Updated:January 27, 2023Recruiting
Condition(s):Metastatic Colorectal Cancer; Cetuximab; Skin ToxicityLast Updated:November 7, 2023Recruiting
Condition(s):Lung Cancer, Nonsmall Cell; Renal Cell Carcinoma; Melanoma; Gastric Cancer; Hepatocellular Carcinoma; Endometrial Cancer; MesotheliomaLast Updated:June 1, 2023Recruiting
Condition(s):Acneiform Eruption Due to Chemical; Xerosis Cutis; ParonychiaLast Updated:February 14, 2024Recruiting
Condition(s):Skin ToxicityLast Updated:September 28, 2023Recruiting
Condition(s):Glioblastoma; Recurrent Glioblastoma; Skin ToxicityLast Updated:December 5, 2023Recruiting
Condition(s):Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Head and Neck CarcinomaLast Updated:December 27, 2023Recruiting
Condition(s):Breast Cancer; Breast Cancer Stage II; Breast Cancer Stage III; Breast Cancer Stage ILast Updated:March 5, 2024Recruiting
Condition(s):Skin Toxicity; ImmunotoxicityLast Updated:February 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.